Lance Armstrong Foundation's $1 million gift launches cancer survivorship clinic at Dana-Farber

August 30, 2004

BOSTON--The Lance Armstrong Foundation has given a $1 million gift to Dana-Farber Cancer Institute to establish the Lance Armstrong Foundation Adult Survivorship Clinic. The clinic, which will be part of the Perini Family Survivors' Center, will expand Dana-Farber's commitment to serving cancer survivors of all ages.

"We have made many significant strides in understanding the lifelong impact of cancer treatment on survivors of childhood cancer, but, until now, limited attention has been focused on survivors of adult-onset cancers," says Lisa Diller, MD, director of the Perini Family Survivors' Center. "With the generous gift from the Lance Armstrong Foundation, we can take this same energy to address the many unmet needs of adult cancer survivors."

The Lance Armstrong Foundation Adult Survivorship Clinic will focus its services and research program to improve care for survivors and the problems they may face after therapy, including infertility, cardiovascular disease, osteoporosis, future cancer risk, and post-trauma stress. The clinic also will develop a robust research program to study these and related issues.

"The Lance Armstrong Foundation is dedicated to addressing the long-term emotional and physical consequences that accompany a cancer diagnosis and treatment," said Mitch Stoller, president and C.E.O of the Lance Armstrong Foundation. "Our partnership with Dana-Farber ensures that together we will investigate and provide for the needs of adult cancer survivors."

The National Cancer Institute estimated that there were nearly 10 million cancer survivors in the United States in 2000. This number is projected to grow as research advances lead to a better understanding of cancer and to better, more effective treatments.

The Lance Armstrong Foundation Adult Survivorship Clinic will build on the success of Dana-Farber's David B. Perini, Jr. Quality of Life Clinic. Since its founding in 1993, the David B. Perini, Jr. Quality of Life Clinic has evolved into a nationally recognized model for addressing the lifelong physical and psychosocial challenges faced by a growing population of childhood cancer survivors. The clinic's faculty provides medical follow-up as well as conducts research into the long-term effects of childhood cancer and cancer treatments.
-end-
About the Lance Armstrong Foundation
The Lance Armstrong Foundation (LAF) believes that in your battle with cancer, knowledge is power and attitude is everything. From the moment of diagnosis we provide the practical information and tools you need to live strong. The LAF focuses its activities on community survivorship programs, national advocacy initiatives, scientific and clinical research grants, and survivorship education and resources, including Live Strong, the LAF's comprehensive resource for cancer survivors. The LAF was founded in 1997 by cancer survivor and champion cyclist Lance Armstrong and is located in Austin, Texas. For more information, visit www.laf.org and www.livestrong.org.

About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. Resources for cancer survivors are available on Dana-Farber's web site, www.dana-farber.org/pat/surviving

Dana-Farber Cancer Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.